PATENT CLAIM ANALYSIS

Application Number: 15742501
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "009400"]

Abstract:
A pharmaceutical composition for use in promoting wound healing and/or accelerating closure of an open wound in a subject in need thereof is disclosed. The composition comprises a therapeutically effective amount of a recombinant polypeptide comprising an amino acid sequence that is at least 80% identical to the amino acid sequence of SEQ ID NO: 2; and a pharmaceutically acceptable vehicle, carrier, diluent, excipients, and/or salt.

Claim (Index 19):
The method of  claim 1 , wherein the recombinant polypeptide comprises no more than 130 amino acid residues.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 86.0
- Lexical Diversity: 1.33929
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14740194', '13646204', '14745562', '13975168', '14740158']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7830755240313086
- 35 USC 102 Novelty (BERT): 0.5150820751282112
- Combined Prediction Score: 0.756276179140999
- Mean Citation Score: 265.7963680000001
- Max Citation Score: 268.07153
- Similarity Product: 167.09210468852638

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test